Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douketis

Showing results (1-10 of 425) with videos related to

Pageof 43
Sort By:
Current Opinion in Hematology|August 12, 2005
Hormone replacement therapy and risk for venous thromboembolism: what's new and how do these findings influence clinical practice?James Douketis
ACP Journal Club|May 3, 2002
Review: stress hyperglycemia after ischemic stroke indicates a greater risk for death in patients without diabetesJames Douketis
ACP Journal Club|March 5, 2003
Heparin plus alteplase reduced morbidity more than heparin alone in submassive pulmonary embolismJames Douketis
Annals of Internal Medicine|May 18, 2011
ACP journal club. Rivaroxaban was noninferior to enoxaparin for preventing short-term recurrent VTE and superior to placebo in continued treatmentJames Douketis
Annals of Internal Medicine|May 18, 2011
ACP journal club. Apixaban reduced VTE and did not increase major bleeding compared with enoxaparin in hip replacementJames Douketis
Evidence-Based Cardiovascular Medicine|December 29, 2005
Factors enhancing the effect of warfarin anti-coagulationJ Douketis
ACP Journal Club|September 5, 2002
Review: postmenopausal estrogen replacement therapy increases the risk for venous thromboembolismJames Douketis
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 16, 1999
Understanding obesityJ D Douketis
Thrombosis Research|February 15, 2003
Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for cliniciansJames D Douketis
Journal of Thrombosis and Haemostasis : JTH|January 31, 2020
Prevention of venous thromboembolism in medical cancer patients: Guidance or guideline?James D Douketis
Pageof 43

Showing results (1-10 of 425) with videos related to

Sort By:
Pageof 43
Current Opinion in Hematology|August 12, 2005
Hormone replacement therapy and risk for venous thromboembolism: what's new and how do these findings influence clinical practice?James Douketis
ACP Journal Club|May 3, 2002
Review: stress hyperglycemia after ischemic stroke indicates a greater risk for death in patients without diabetesJames Douketis
ACP Journal Club|March 5, 2003
Heparin plus alteplase reduced morbidity more than heparin alone in submassive pulmonary embolismJames Douketis
Annals of Internal Medicine|May 18, 2011
ACP journal club. Rivaroxaban was noninferior to enoxaparin for preventing short-term recurrent VTE and superior to placebo in continued treatmentJames Douketis
Annals of Internal Medicine|May 18, 2011
ACP journal club. Apixaban reduced VTE and did not increase major bleeding compared with enoxaparin in hip replacementJames Douketis
Evidence-Based Cardiovascular Medicine|December 29, 2005
Factors enhancing the effect of warfarin anti-coagulationJ Douketis
ACP Journal Club|September 5, 2002
Review: postmenopausal estrogen replacement therapy increases the risk for venous thromboembolismJames Douketis
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 16, 1999
Understanding obesityJ D Douketis
Thrombosis Research|February 15, 2003
Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for cliniciansJames D Douketis
Journal of Thrombosis and Haemostasis : JTH|January 31, 2020
Prevention of venous thromboembolism in medical cancer patients: Guidance or guideline?James D Douketis
Pageof 43